Inhaled Nitric Oxide
HT940827Q0002
DEFENSE HEALTH AGENCY (DHA) → DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY → DEFENSE HEALTH AGENCY
- Posted
- Oct 8, 2026
- Deadline
- Oct 22, 2026 · 5:00 PM CDT
- Est. Value
- Not specified
- Location
- 0, TX
Live Opportunity Feed
HT940827Q0002
DEFENSE HEALTH AGENCY (DHA) → DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY → DEFENSE HEALTH AGENCY
The Defense Health Agency is conducting a sources sought notice for the procurement of Inhaled Nitric Oxide, a specialized pharmaceutical gas used primarily in critical care and neonatal settings. The notice was posted on October 8, 2026, with responses due by October 22, 2026. This is a market research effort, and qualified pharmaceutical suppliers, particularly those with experience in military medical logistics, should consider responding to demonstrate capability and interest.
See how well this opportunity matches your company's capabilities, NAICS codes, and set-asides.
Know who holds the current contract, their award amounts, and contract history.
AI-generated proposal outlines, compliance checklists, and win-theme suggestions.
Starts at $49/month. Cancel anytime.